Corepharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for COREPHARMA
COREPHARMA has twenty-one approved drugs.
There is one tentative approval on COREPHARMA drugs.
Summary for Corepharma
| US Patents: | 0 |
| Tradenames: | 19 |
| Ingredients: | 19 |
| NDAs: | 21 |
| Patent Litigation for Corepharma: | See patent lawsuits for Corepharma |
Drugs and US Patents for Corepharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corepharma | DECLOMYCIN | demeclocycline hydrochloride | TABLET;ORAL | 050261-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Corepharma | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 218372-003 | Sep 17, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Corepharma | LISINOPRIL | lisinopril | TABLET;ORAL | 076102-004 | Sep 30, 2002 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
